IL-27/IL-35 EBI3 Subunit (Dimer), (Heterodimer), (Monomer) anticorps

N° du produit ABIN2665152

Cet anticorps Rat Monoclonal détecte spécifiquement dans FACS. Il présente une réactivité envers Souris.

Aperçu rapide pour IL-27/IL-35 EBI3 Subunit (Dimer), (Heterodimer), (Monomer) anticorps (ABIN2665152)

Antigène: IL-27/IL-35 EBI3 Subunit

Reactivité: Souris

Hôte: Rat

Clonalité: Monoclonal

Conjugué: Inconjugué

Application: Flow Cytometry (FACS)

Clone: J053B5

Détail du produit

Épitope: Dimer, Heterodimer, Monomer

Purification: The antibody was purified by affinity chromatography.

Isotype: IgG2a

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: 0.5 mg/mL

Buffer: Phosphate-buffered solution, pH 7.2, containing 0.09 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C

Stockage commentaire: The antibody solution should be stored undiluted between 2°C and 8°C.

Détail du antigène

Antigène: IL-27/IL-35 EBI3 Subunit

Autre désignation: IL-27/IL-35 EBI3

Sujet: EBI3 is an IL-12 p40-related protein that can heterodimerized with IL-12 p35 to form IL-35, or with an IL-12 p35-related protein, p28, to form IL-27. It is produced by antigen-presenting cells such as B cells, monocytes, and dendritic cells (DCs) following stimulation through TLR. It can regulate T cell differentiation and proliferation. Both IL-27 and IL-35 are anti-inflammatory cytokines that are able to inhibit Th17 generation, promote Th1 differentiation, increase cytolytic activity of CD8+ T cells, and impact B cell differentiation and immunoglobulin production. IL-35 is also involved in tumorigenesis and is a promising biomarker for assessing tumor progression and prognosis in clinical settings.